Roche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.

The randomised trial of 52 weeks was conducted in 11 countries and included over 500 patients, Lupin said.

Ranbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.